Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Nat Genet. 2022 May;54(5):593-602. doi: 10.1038/s41588-022-01051-w. Epub 2022 May 2.
Improved understanding of genetic regulation of the proteome can facilitate identification of the causal mechanisms for complex traits. We analyzed data on 4,657 plasma proteins from 7,213 European American (EA) and 1,871 African American (AA) individuals from the Atherosclerosis Risk in Communities study, and further replicated findings on 467 AA individuals from the African American Study of Kidney Disease and Hypertension study. Here, we identified 2,004 proteins in EA and 1,618 in AA, with most overlapping, which showed associations with common variants in cis-regions. Availability of AA samples led to smaller credible sets and notable number of population-specific cis-protein quantitative trait loci. Elastic Net produced powerful models for protein prediction in both populations. An application of proteome-wide association studies to serum urate and gout implicated several proteins, including IL1RN, revealing the promise of the drug anakinra to treat acute gout flares. Our study demonstrates the value of large and diverse ancestry study to investigate the genetic mechanisms of molecular phenotypes and their relationship with complex traits.
对蛋白质组遗传调控的深入了解可以促进对复杂性状因果机制的识别。我们分析了动脉粥样硬化风险社区研究中 7213 名欧洲裔美国人(EA)和 1871 名非裔美国人(AA)个体的 4657 种血浆蛋白数据,并在非洲裔美国人肾脏病和高血压研究中对 467 名 AA 个体的发现进行了进一步复制。在这里,我们在 EA 中鉴定出 2004 种蛋白质,在 AA 中鉴定出 1618 种蛋白质,其中大多数重叠,这些蛋白质与顺式区域的常见变异有关。AA 样本的可用性导致了更小的可信集和大量特定于人群的顺式蛋白质数量性状基因座。弹性网络为两个群体的蛋白质预测生成了强大的模型。全蛋白质组关联研究在血清尿酸和痛风中的应用表明了包括 IL1RN 在内的几种蛋白质的相关性,揭示了药物 anakinra 治疗急性痛风发作的前景。我们的研究表明,大规模和多样化的祖先研究对于研究分子表型的遗传机制及其与复杂性状的关系具有重要价值。
BMC Med Genomics. 2011-2-4
J Cachexia Sarcopenia Muscle. 2025-2
Pediatr Rheumatol Online J. 2025-9-2
J R Stat Soc Series B Stat Methodol. 2020-12
Science. 2021-11-12
Nat Commun. 2020-12-16
Nucleic Acids Res. 2021-1-8